An investor in NASDAQ:AKTX shares filed a lawsuit over alleged violations of Federal Securities Laws by Akari Therapeutics PLC. Investors who purchased shares of Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. According to the complaint the plaintiff alleges on behalf of purchasers of Akari […]